Orchestra BioMed Holdings, Inc. (OBIO)
(Delayed Data from NSDQ)
$2.44 USD
-0.07 (-2.79%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $2.43 -0.01 (-0.41%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Orchestra BioMed Holdings, Inc. has a market cap of $97.00M, which represents its share price of $2.51 multiplied by its outstanding shares number of 38.64M. As a small-cap company, OBIO's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
OBIO 2.44 -0.07(-2.79%)
Will OBIO be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for OBIO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OBIO
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Beats Revenue Estimates
CRISPR Therapeutics AG (CRSP) Reports Q2 Loss, Lags Revenue Estimates
OBIO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Tops Revenue Estimates
Ultragenyx (RARE) Reports Q1 Loss, Misses Revenue Estimates
Orchestra BioMed Holdings, Inc. (OBIO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Other News for OBIO
The technical outlook for OBIO is unchanged after it falls 2.79% on September 19
Stochastic Buy Signal appears for OBIO after 2.03% move
Technical picture remains unchanged for OBIO after it falls 2.77% on September 17
OBIO falls 2.69% on September 16, leaving the technical picture intact
Is OBIO signaling selling opportunity? 20 Day Moving Average Resistance shows up after rising 1.17%